Akari Therapeutics ADR (AKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,082 | -16,846 | -16,467 | -35,399 | -18,141 |
| Depreciation Amortization | 9 | 19 | 36 | 42 | 40 |
| Accounts payable and accrued liabilities | -248 | 2,380 | -3,690 | 12 | -672 |
| Other Working Capital | -56 | 3,091 | -4,455 | 811 | -1,450 |
| Other Operating Activity | 426 | -1,562 | 1,995 | 2,935 | -4,401 |
| Operating Cash Flow | $-16,950 | $-12,918 | $-22,580 | $-31,599 | $-24,625 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 10,022 | -10,022 |
| PPE Investments | N/A | N/A | N/A | -37 | -55 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 10 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $9,985 | $-10,067 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 25,074 | 12,648 | 306 | 15,672 | N/A |
| Financing Cash Flow | $25,074 | $12,648 | $306 | $15,672 | $N/A |
| Exchange Rate Effect | 201 | 34 | -7 | -50 | -130 |
| Beginning Cash Position | 5,732 | 5,968 | 28,249 | 34,241 | 68,920 |
| End Cash Position | 14,056 | 5,732 | 5,968 | 28,249 | 34,099 |
| Net Cash Flow | $8,324 | $-236 | $-22,281 | $-5,992 | $-34,821 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,950 | -12,918 | -22,580 | -31,599 | -24,625 |
| Capital Expenditure | N/A | N/A | N/A | -37 | -55 |
| Free Cash Flow | -16,950 | -12,918 | -22,580 | -31,636 | -24,679 |